Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 228

The DOI matches its Crossref record.

Cardiac phosphodiesterase 5 (cGMP‐specific) modulates β‐adrenergic signaling in vivo and is down‐regulated in heart failure

SENZAKI, HIDEAKI, SMITH, CAROLYN J., JUANG, GEORGE J., ISODA, TAKAYOSHI, MAYER, SHARON P., OHLER, ANDREAS, PAOLOCCI, NAZARENO, TOMASELLI, GORDON F., HARE, JOSHUA M., KASS, DAVID A.·2001·The FASEB Journal

Abstract

Recent studies implicate increased cGMP synthesis as a postreceptor contributor to reduced cardiac sympathetic responsiveness. Here we provide the first evidence that modulation of this interaction by cGMP‐specific phosphodiesterase PDE5A is also diminished in failing hearts, providing a novel mechanism for blunted β‐adrenergic signaling in this disorder. In normal conscious dogs chronically instrumented for left ventricular pressure‐dimension analysis, PDE5A inhibition by EMD82639 had modest basal effects but markedly blunted dobutamine‐enhanced systolic and diastolic function. In failing hearts (tachypacing model), however, EMD82639 had negligible effects on either basal or dobutamine‐stimulated function. Whole myocardium from failing hearts had 50% lower PDE5A protein expression and 30% less total and EMD92639‐inhibit‐able cGMP‐PDE activity. Although corresponding myo‐cyte protein and enzyme activity was similar among groups, the proportion of EMD82639‐inhibitable activity was significantly lower in failure cells. Immunohis‐tochemistry confirmed PDE5A expression in both the vasculature and myocytes of normal and failing hearts, but there was loss of z‐band localization in failing myocytes that suggested altered intracellular localization. Thus, PDE5A regulation of cGMP in the heart can potently modulate β‐adrenergic stimulation, and alterations in enzyme localization and reduced synthesis may blunt this pathway in cardiac failure, contributing to dampening of the β‐adrenergic response.—Senzaki, H., Smith, C. J., Juang, G. J., Isoda, T., Mayer, S. P., Ohler, A., Paolocci, N., Tomaselli, G. F., Hare, J. M., Kass, K. A. Cardiac phosphodiesterase 5 (cGMP‐specific) modulates β‐adrenergic signaling in vivo and is down‐regulated in heart failure. FASEB J . 15, 1718—1726 (2001)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.00-0538com

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 228

Metadata

Authors
SENZAKI, H., SMITH, C. J., JUANG, G. J., ISODA, T., MAYER, S. P., OHLER, A., PAOLOCCI, N., TOMASELLI, G. F., HARE, J. M., & KASS, D. A.
Venue
The FASEB Journal
Publisher
Wiley
Published
2001-08
Volume
15
Issue
10
Pages
1718-1726
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W1995896668
Cited by
228
References
0
FWCI
3.91
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cardiac phosphodiesterase 5 (cGMP‐specific) modulates β‐adrenergic signaling in vivo and is down‐regulated in heart failure. https://app.cochat.ai/papers/10.1096/fj.00-0538com
The paper
SENZAKI, H., SMITH, C. J., JUANG, G. J., ISODA, T., MAYER, S. P., OHLER, A., PAOLOCCI, N., TOMASELLI, G. F., HARE, J. M., & KASS, D. A. (2001). Cardiac phosphodiesterase 5 (cGMP‐specific) modulates β‐adrenergic signaling in vivo and is down‐regulated in heart failure. The FASEB Journal. https://doi.org/10.1096/fj.00-0538com

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.